Lungpacer Medical has received FDA Premarket Approval for the AeroPace System
Dedicated to
Natural Breathing
Designed to help patients wean off
a ventilator and breathe on their own
Without a strong diaphragm it is impossible to breathe independently*
Artificial breathing support from a ventilator may weaken the diaphragm muscle more than 50% in less than one day* making it difficult to regain independent breathing.
Lungpacer is designed as a personal trainer for the diaphragm muscle*
Lungpacer’s AeroPace System is designed to stimulate the nerves that activate the diaphragm with repetitive exercises for 10-20 minutes twice per day to rebuild diaphragm strength and empower natural, independent breathing*.
Potential Benefits
AcceleratedWeaning
Fewer MVComplications
Cost Effective
Reduced ICU Days
Seamless Integration
Outcomes from AeroPace Clinical Studies Showed
Using AeroPace compared to Standard of Care, more patients weaned.
Up to 35% reduced risk of remaining on MV at day 30
0
%
Up to 46% fewer reintubations and tracheostomies
0
%
Fewer days on MVin the ICU
3
Lungpacer therapy provides an exciting potential solution to help mechanically ventilated patients return to natural breathing more quickly.
Dr. Joseph Shrager - Stanford University School of Medicine
Lungpacer Medical Research
Scientific Abstracts
& Presentations
& Presentations
10
Peer Reviewed
Publications
Publications
5
Patients
Studied
Studied
10
+
Learn more about results and trends from more than seven years of Lungpacer research.
Lungpacer AeroPace System
For patients unable to breathe on their own, the AeroPace therapy is designed to provide repetitive exercises, to rebuild diaphragm muscle strength critical to healthy breathing.
The AeroPace System is indicated to improve weaning success – increase weaning, reduce ventilator days, and reduce reintubation – in patients ages 18 years or older on mechanical ventilation at least 96 hours and who have not weaned.